Search clinical trials for: unresectable stage III or IV melanoma
Total 218053 results
-
NYU Langone HealthBristol-Myers Squibb; Daiichi Sankyo, Inc.CompletedMelanomaUnited States
-
Eisai Inc.Terminated
-
Bart NeynsVrije Universiteit BrusselCompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVBelgium
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Jewish General HospitalActive, not recruitingUntreated Stage III Melanoma or Stage IV MelanomaCanada
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
NYU Langone HealthTerminated
-
Takara Bio Inc.CompletedMelanoma Stage IV | Melanoma Stage IIIJapan
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
University Health Network, TorontoCompletedMetastatic, Stage III or Stage IV, MelanomaCanada
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
University of California, IrvineGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Takara Bio Inc.TheradexCompletedMalignant MelanomaUnited States
-
Providence Health & ServicesTerminated
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage III Skin MelanomaUnited States
-
GlaxoSmithKlineNo longer available
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
Celldex TherapeuticsTerminatedUnresectable Stage III or Stage IV MelanomaUnited States
-
California Cancer ConsortiumNational Cancer Institute (NCI)TerminatedKidney CancerUnited States
-
University of UtahTerminatedStage III or IV MelanomaUnited States
-
Bristol-Myers SquibbNo longer availableStage III (Unresectable) or Stage IV Advanced MelanomaUnited States, Canada, Argentina, Colombia, Peru, Brazil
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
Nantes University HospitalTerminated
-
Eisai Inc.TerminatedUnresectable Stage III Melanoma | Wild Type BRAF Stage IV MelanomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
Rabih SaidAgenus Inc.Withdrawn
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Completed
-
Astellas Pharma IncCompletedMelanomaUnited States, Canada
-
University of UtahCompleted
-
BayerAmgenCompletedMelanoma | CancerUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterWithdrawnSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Herlev HospitalCompletedMalignant Melanoma With MetastasisDenmark
-
National Cancer Institute (NCI)CompletedSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
INSYS Therapeutics IncNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IIIB Breast Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell... and other conditionsUnited States